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Competitive effects of hypokalemia and volume depletion on
plasma renin activity, aldosterone and catecholamine concentrations
in hemodialysis patients. The effects of isokalemic and hypokalemic
ultrafiltration dialysis on plasma renin activity (PRA), aldosterone
(ALDO) and plasma catecholamine (CA) concentrations were in-
vestigated in eight patients with end-stage renal failure. Plasma
sodium concentration was kept constant during each hemodialysis,
but plasma potassium decreased (4.8 to 3.4 mEq/liter, P < 0.001)
only in the hypokalemic dialysis group. The falls in mean body
weight (—1.77 vs. —1.66 kg) and mean blood pressure (125 to 109
vs. 126 to 108 mm Hg) were similar in the isokalemic and hypoka-
lemic dialysis patient groups. PRA increased during dialysis both
in the isokalemic (4.55 to 8.85 ng/ml/hr, P < 0.02) and hypoka-
lemic (2.18 to 3.19 ng/ml/hr, P < 0.01) groups. These changes in
body wt, blood pressure, and PRA were not significantly different
in the isokalemic and hypokalemic dialyses. There were, however,
important differences between the isokalemic and hypokalemic
groups. While the mean ALDO increased (105 to 198 pg/mI, P <
0.05) during the isokalemic dialyses, ALDO actually fell signifi-
cantly during the hypokalemic dialyses (120 to 36.8 pg/mI, P <
0.005). Prior to dialysis, CA's were increased significantly above
normal values in both dialysis groups. With dialysis, CA's did not
change significantly in the isokalemic group and actually fell in the
hypokalemic group (1.27 to .93 ng/ml, P < 0.02). In spite of
decreased body wt and blood pressure in both groups, heart rate
increased only during the isokalemic dialysis. These results demon-
strate a dominant effect of a fall in plasma potassium concentra-
tion to suppress ALDO, despite a concomitant fall in blood pres-
sure and body wt and a rise in PRA. The elevated CA
concentrations in these patients may possibly interact with sodium
balance and contribute to the hypertension in these patients. The
fall in CA's and absence of tachycardia during hypokalemic
dialysis raises the possibility that a fall in plasma potassium con-
centration may cause or unmask aut000mic insufficiency in these
chronic renal failure patients who are predisposed to this disorder.
Effets compétitifs de l'hypokaliémie et de Ia diminution du volume
sur l'activité rénine et lea concentrations plasmatiques d'aldostérone
et de catécholamines chez les malades en hémodialyse. Les effets de
Ia dialyse par ultrafiltration isokaliémique et hypokaliemique sur
l'activité rénine plasmatique (PRA), l'aldostérone (ALDO) et les
catécholamines (CA) plasmatiques ont été étudiés chez huit mal-
ades au stade terminal de I'insuffisance rénale. La concentration
plasmatique de sodium a été maintenue constante au cours de
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toutes les hemodialyses mais Ic potassium plasmatique n'a diminué
(4,8 a 3,4 mEq/litre, P < 0,001) que dans Ic groupe soumis a une
dialyse hypokaliémique. Les diminutions rnoyennes du poids cor-
porel (— 1,77 vs. — 1,66 kg) et de Ia pression artérielle moyenne (125
a 109 vs. 126 a 108 mm Hg) ont été semblables dans les deux
groupes. PRA a augmenté au cours de Ia dialyse aussi bien dans Ic
groupe isokaliémique (4,55 a 8,85 ng/ml/hr, P < 0,02) que dans Ic
groupe hypokaliémique (2,18 a 3,19 ng/mI/hr, P < 0,01). Ces
modifications do poids corporel, de Ia pression artérielle et de PRA
ne sont pas significativement différentes darts les deux groupes. Des
differences importantes, cependant, sont apparues entre les deux
groupes. Alors que l'ALDO moyenne augmente (105 a 198 pg/mI,
P < 0,05) au cours de Ia dialyse isokaliémique, dIe chute signifi-
cativement au coors de Ia dialyse hypokaliCmique (120 a 36,8
ng/ml, P < 0,005). Avant Ia dialyse les CA sont significativement
supérieures aux valeurs normales dans les deux groupes. Avec Ia
dialyse les CA ne sont pas significativenient modifiées dans Ic
groupe isokaliCmique et chutent dans le groupe hypokaliemique(1,27 a 0,93 ng/ml, P < 0,02). Malgré Ia diminution du poids
corporel et de Ia pression artérielle dans les deux groupes, Ia
fréquence cardiaque n'augmente qu'au cours de Ia dialyse isokalié—
mique. En conclusion, ces résultats obtenus chez des malades
soumis a l'hCmodialyse démontrent l'effet d'une diminution du
potassium plasmatique dans le sens de Ia suppression de I'ALDO,
effet predominant malgré Ia diminution de Ia pression artérielle et
du poids corporel et I'augmentation de PRA concomitants.
L'augmentation des CA, chez ces malades, a peut-Ctre une inter-
action avec Ic bilan do sodium et contribue a I'hypertension. La
diminution des CA et I'absence de tachycardie au cours de Ia
dialyse hypokaliCmique soulCve l'hypothèse qu'une chute de Ia
concentration de potassium plasmatique puisse determiner ou dé—
masquer une insuffisance du système rerveux autonome chez ces
malades atteints d'insuffisance rénale chronique, malades dont on
sait qu'ils soot exposés a de tels désordres.
In nephrectomized patients, dialysis ultrafiltration
has been found to be associated with a rise in plasma
aldosterone concentration [1]. This observation sug-
gests that a rise in plasma renin activity is not a
necessary accompaniment of the effect of volume de-
pletion on plasma aldosterone. During ultrafiltration
dialysis, however, a fall in plasma sodium concentra-
tion also may occur and account for any rise in
plasma aldosterone concentration [1, 2]. Alterna-
tively, any failure of ultrafiltration dialysis to stimu-
late plasma aldosterone levels could be related to a
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concomitant fall in plasma potassium concentration
[3—5]. Moreover, circulating catecholamines could af-
fect either the release of renin or aldosterone during
ultrafiltration dialysis.
In the present studies, ultrafiltration dialysis was
performed on chronic renal failure patients possess-
ing their own kidneys. During all dialyses, plasma
sodium concentration was kept constant. In this set-
ting, the effect of isokalemic and hypokalemic ultra-
filtration dialysis on plasma renin, aldosterone, and
catecholamine concentrations was examined. iso-
kalemic ultrafiltration dialysis was associated with a
rise in plasma renin and aldosterone but not plasma
catecholamine concentrations. In contrast, hypokale-
mic ultrafiltration dialysis was associated with a rise in
plasma renin activity, but a fall in plasma aldosterone
and catecholamine levels, Although plasma cate-
cholamine levels did not increase with ultrafiltration
dialysis in either group, the baseline levels of plasma
catecholamines in all the patients with chronic renal
failure were well above levels found in normal sub-
jects.
From these results, we conclude that hypokalemia
may predominate over volume depletion and a
plasma renin increase as a regulator of plasma al-
dosterone concentration in chronic renal failure pa-
tients, In these patients, the rise in plasma renin activ-
ity during volume depletion was neither enhanced by
hypokalemia nor accompanied by a rise in plasma
catecholamines. Lastly, although plasma cate-
cholamine concentrations were uniformly elevated in
these patients with end-stage renal failure, these high
catecholamine levels were not stimulated by iso-
kalemic volume depletion, and actually fell during
hypokalemic volume depletion. This latter finding
suggested that hypokalemia might possibly cause or
uncover autonomic insufficiency in the uremic pa-
tient. This possibility was supported by the finding
that isokalemic, but not hypokalemic, ultrafiltration
dialysis significantly increased heart rate in these
dialysis patients.
Methods
Eight, stable, chronic hemodialysis patients, taking
no antihypertensive medicines, were utilized in the
study. Informed consent was obtained prior to entry
into the study. All of the patients were male, and the
mean age was 48 5 (sEM) yr; the mean length of
time on dialysis was 45 14 months. All patients
possessed their own kidneys. All patients were
dialyzed for six hours on hollow fiber dialyzers (Cobe
Hollow Fiber HF 130 [1.3 m2]), using a central deliv-
ery system (Drake-Willock, model 4009).
Two separate dialysis protocols were followed. In
one set of seven dialyses involving five of the patients,
the dialysate potassium concentration was adjusted
so that plasma potassium did not change by more
than 0.3 mEq/liter. In another group of dialyses, in
which eight patients (including the original five pa-
tients) underwent 12 dialyses, plasma potassium con-
centration was allowed to decrease. In both sets of
dialyses, the goal was for the patients to lose weight
by ultrafiltration, and all patients lost at least 0.5 kg
during the dialysis period.
All patients were weighed before and after dialysis;
food consumed during dialysis was weighed and sub-
tracted from the postdialysis weight. Blood pressures
and heart rates were measured in the supine position
immediately before and after dialysis. No patient had
any adverse effects during either dialysis protocol. All
blood samples were obtained at the beginning and
termination of the dialysis from the patient's arterial
dialysis line. Plasma for measurement of aldosterone
and peripheral renin activity was collected in iced
tubes, cold centrifuged, and frozen immediately. The
method of analysis of aldosterone and plasma renin
activity was by radioimmunoassay [6, 7]. In our labo-
ratory, the mean plasma renin activity and aldoste-
rone concentrations in normal individuals who were
upright for two hours and on a normal sodium intake
(113 mEq/day) were 4.4 0.9 ng/ml/hr and 334 30
pg/mI, respectively. Plasma for measurement of cate-
cholamines was collected in heparinized tubes and
centrifuged at 4°C. Plasma proteins were removed
following the addition of perchloric acid to a final
concentration of 0.lN. Catecholamine concentra-
tions were determined by a modification of the enzy-
matic technique of Coyle and Henry [8], as described
by Nelson and Molinoff [9]. The mean ambulatory
catecholamine concentration in six normal individ-
uals was 0.36 0.06 ng/ml. Electrolyte concentra-
tions were determined by flame photometry in the
routine chemistry laboratory.
Statistics were performed using Student's i test and
rank sum test. Data are presented as the mean the
standard error of the mean (sEM), and a P value of
<0.05 was considered significant.
Results
Changes in weight during dialysis. Patients in the
isokalemic dialysis group had a weight decrease from
70 + 5 to 68 5 kg (P <0.02) during dialysis; the
hypokalemic group declined from 75 2 to 73 2 kg
(P < .001) during dialysis. Both the absolute weight
losses (1.8 vs. 1.7 kg) and the percentage of body wt
declines (2.3 vs. 2.7%) were thus similar in both
dialysis groups. Although not significantly different,
the discrepancy between the mean predialysis weights
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of the groups is accounted for by higher weights of
the three additional subjects in the hypokalemic
_________________________________________
group.
Changes in blood pressure during dialysis (Fig. I).
Mean blood pressure in the isokalemic dialysis group
declined from 125 5 to 109 7 mm Hg (P < 0.001)
during dialysis, and the hypokalemic group had a
decrement in mean blood pressure from 126 3 to
108 + 6 mm Hg (P < 0.001). The change in mean
blood pressure was, therefore, similar in both isoka-
lemic and hypokalemic groups.
Changes in heart rate during dialysis (Fig. 2). The
isokalemic dialysis group had a significant increase in
heart rate from 88 5 beats/mm before, to 99 4
beats/mm after dialysis (P < 0.02). In the hypo-
kalemic group, however, heart rate was not signifi-
cantly altered by ultrafiltration dialysis (87 3 beats/
mm before, to 90 1 beats/mm after dialysis). The
postdialysis heart rate was significantly greater in the
isokalemic group (P < 0.025).
Changes in sodium concentration during dialysis.
________
Plasma sodium concentration was held constant dur-
ing dialysis in both groups of dialyses. In the iso
_________________________________________
kalemic group, the sodium was 136 1 mEq/liter be-
fore and 138 1 mEq/liter after dialysis (P = NS); in
the hypokalemic group, the serum sodium was 139
I before and 138 I after dialysis (P = NS).
Changes in serum potassium during dialysis. The
isokalemic dialysis group had a mean serum potas-
sium concentration of 4 0.3 mEq/liter before and 4
0.2 mEq/liter after dialysis. Thus, no significant
change in serum potassium was allowed to occur in
this group. In contrast, in the hypokalemic group of
dialyses, mean serum potassium concentration fell
from 4.8 0.2 mEq/liter before, to 3.4 0.1
mEq/liter after dialysis (P < 0.001). Comparison
between groups indicated that the postdialysis potas-
sium concentration was significantly lower (P < 0.02)
in the hypokalemic patients.
Changes in plasma renin activity during dialysis. In
both groups, a significant increase in plasma renin
activity was seen during dialysis. The isokalemic
group had an increase in plasma renin activity from
4.6 1.8 to 8.9 3.6 ng/ml/hr (P < 0.02), and the
hypokalemic group had an increase from 2.2 0.5 to
3.2 0.8 ng/ml/hr (P < 0.01). Although not signifi-
cantly different, the lower predialysis plasma renin in
the hypokalemic group may have been influenced by
the higher prediaJysis potassium concentration in
that group; additionally, the three subjects added to
the hypokalemic group had plasma renin activities
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Fig. 2. The isokalemic dialysis group showing a significant increase in
pulse during the course of dialysis. The hypokalemic dialysis group,
in contrast, had no significant change in pulse.
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Fig. 1. A comparable and significant fall in blood pressure observed
in both the isokalemic (solid line) and hypokalemic (dashed line)
dialysis groups.
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which were lower, and thus lowered the mean value.
The inclusion of these three subjects in the analysis
__________________________________________
of the results did not, however, alter the statistical sig
________
nificance of the other variables analyzed in the paper.
Changes in plasma aldosterone concentration during
dialysis (Fig. 3). In the isokalemic group of dialyses,
plasma aldosterone concentration increased from 105
61 to 198 + 72 pg/mI (P < 0.05). In striking
contrast, despite a comparable amount of volume
depletion and a significant increase in plasma renin
activity, a decrease in aldosterone concentration oc-
curred, from 120 40 to 37 18 pg/mI (P < 0.005),
with the hypokalemic dialyses. The predialysis
plasma aldosterone values in the groups were com-
parable, but the postdialysis values were significantly
different (P < 0.05).
Changes in catecholamines during hemodialysis (Fig.
4). The predialysis plasma catecholamine concentra-
tions were significantly higher in both isokalemic and
hypokalemic groups when compared to normals (P <
0.01). In the isokalemic dialyses, catecholamine con-
centration was 1.77 0.43 ng/mI before and 1.51
0.21 ng/ml after dialysis (P = NS). In the hypo
______________________________________
kalemic patients, the catecholamine concentration
decreased from 1.27 0.17 ng/ml before, to 0.93
0.08 ng/mI after dialysis (P < 0.02). The postdialysis
catecholamine concentration was significantly lower
in the hypokalemic group than the isokalemic group
(P < 0.025).
Changes in serum bicarbonate, calcium, magnesium,
and cortisol during dialysis. An equivalent increase in
serum bicarbonate occurred in both groups during
dialysis, from 21.1 0.8 to 24,4 0.5 mEq/liter (P <
0.001) in the isokalemic dialysis group, and from 20.3
0.9 to 24.5 0.7 mEq/liter (P < 0.001) in the
hypokalemic dialysis group. Serum calcium did not
change in either group. Isokalemic dialysis patients
had a calcium concentration of 9.7 + 0.5 mEq/liter
before dialysis and a postdialysis calcium concentra-
tion of 10.0 0.4 mEq/Iiter, P = NS. The hypo-
kalemic patients' calcium concentrations were 9.8
0.3 mEq/liter before and 9.8 0.3 mEq/liter after
dialysis, P = NS. Four of the patients had serum
cortisol measured during isokalemic and hypo-
kalemic dialyses, and no significant change was ob-
served during either experimental condition. Sim-
ilarly, the serum magnesium concentrations were not
significantly altered during dialysis.
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Fig. 4. The catecholamine concentration from a group of normals,
depicted by the hatched area at the bottom of the graph. Both
dialysis groups had significantly higher predialysis catecholamine
concentrations than normals. lsokalemic dialysis patients had no
significant change in catecholamine concentrations, whereas hypo-
kalemic dialysis patients had a significant fall in catecholamine
concentrations.
Fig. 3. The isokalemic dialysis group showing a significant increase in
aldosterone concentration during dialysis. The hypokalemic dialysis
group, however, underwent a significant reduction in aldosterone
concentration during dialysis.
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Discussion
Several potential factors may be involved in the
regulation of plasma aldosterone concentration in
patients with advanced chronic renal failure. In-
cluded among these are changes in plasma sodium,
potassium, and renin concentrations, or some other
consequence of volume depletion, such as alterations
in plasma catecholamines.
A fall in plasma sodium concentration has been
suggested to stimulate plasma aldosterone [2]. Dur-
ing hemodialysis, plasma sodium concentration fre-
quently decreases and, thus, could account, at least in
part, for the increase in plasma aldosterone that has
been observed during fluid removal by ultrafiltration
in nephrectomized patients [1, 2]. While such studies
in nephrectomized patients seem clearly to in-
criminate a pathway independent of the renin-angio-
tensin system, the precise pathway has not been de-
fined. In the present study, there can be little doubt
that plasma aldosterone concentration may be al-
tered in chronic renal failure patients in the absence
of changes in plasma sodium concentration. Changes
in plasma cortisol, calcium, and magnesium also
failed to explain the observed effects of ultrafiltration
hemodialysis on plasma aldosterone concentration.
The present results provide further evidence that
changes in plasma aldosterone concentration can
clearly be dissociated from changes in plasma renin
activity. This dissociation between plasma aldoste-
rone and renin was primarily accomplished by alter-
ing plasma potassium concentration. During iso-
kalemic ultrafiltration hemodialysis, rises in both
plasma aldosterone and renin were observed. Dur-
ing ultrafiltration dialysis, however, which lowered
blood pressure and body weight by a comparable
degree, but allowed plasma potassium to fall (4.8 to 3.4
mEq/liter), plasma renin activity rose but plasma a!-
dosterone concentration fell significantly. These find-
ings, therefore, demonstrate that hypokalemia of a
degree frequently observed during ultrafiltration
dialysis may dominate over volume depletion, a fall
in blood pressure, and a rise in plasma renin activity
to suppress plasma aldosterone concentration. The
physiologic importance of such a role of plasma po-
tassium to influence plasma aldosterone concentra-
tion in patients with end-stage renal failure remains
to be defined, but obviously would have to relate to
the extrarenal effects of aldosterone. The distribution
of sodium and water between intracellular and extra-
cellular compartments, and thus, the control of blood
pressure could be such an extrarenal effect of aldoste-
rone. Another extrarenal effect may involve modu-
lation of serum electrolytes through effects on the
gastrointestinal system [10]. Also, it should be em-
phasized that there is evidence that aldosterone is
involved in the urinary excretion of both sodium and
potassium over a wide range of renal function, in-
cluding patients with advanced renal failure who do
not require maintenance hemodialysis [11].
Another observation in the present study was the
finding of high baseline plasma catecholamine con-
centrations in these patients with advanced renal fail-
ure. Preliminary results using the fluorirnetric method
of analysis of plasma catecholamines have suggested
high concentrations in uremic patients [12, 13]. This
finding was confirmed in the present study using the
more sensitive radiometric enzymatic technique [8,
9]. A preliminary communication, however, also sug-
gested a correlation between plasma catecholamine
and renin concentrations [13]. In the present study,
plasma renin activity rose during both isokalemic and
hypokalemic dialysis, and yet no detectable increase
in plasma catecholamine concentrations was ob-
served. The high baseline concentrations of plasma
catecholamines are probably due both to a decreased
urinary excretion and diminished metabolism which
may be related to a decline in catechol-O-methyl
transferase activity [13]. In any case, it is not unrea-
sonable to suggest that the high concentrations of
plasma catecholamines present in patients with ad-
vanced renal failure may be a factor in the high
incidence of hypertension in this population. In this
regard, it is interesting to note that Kim et al [14]
have demonstrated that an increase in peripheral vas-
cular resistance, in addition to an increase in extra-
cellular fluid volume, is involved in the hypertension
of patients on maintenance hemodialysis. While the
role of catecholamines in the hypertension of chronic
renal failure is intriguing, a comparison of cate-
cholamines in normotensive and hypertensive dialysis
patients, however, will be necessary to confirm this
possibility.
The high plasma catecholamine concentrations in
patients with advanced renal failure may also relate
to dialysis hypotensive syndromes. Orthostatic hypo-
tension is characteristic of patients with pheochro-
mocytoma and presumably relates to the high level of
supine sympathetic tone which does not increase fur-
ther during the venous pooling which occurs on
standing. Similarly, the high concentration of plasma
catecholamines in our patients with advanced renal
failure did not increase during ultrafiltration dialysis.
This failure of the concentrations of plasma cate-
cholamines to rise may relate to their initial high
concentration or to the fact that clinical or subclinical
autonomic insufficiency is a frequent accompaniment
of advanced renal failure [15, 16]. In any case, the
occurrence of a fall in blood pressure at the onset of
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dialysis prior to fluid removal by ultrafiltration could
result from the failure of sympathetic tone to increase
in response to the hemodynamic stresses of hemo-
dialysis, eg., extracorporeal blood in dialysis lines.
It is also interesting to note that not only did
plasma catecholamines fail to rise in response to re-
moval of fluid by ultrafiltration with a consequent fall
in blood pressure, but hypokalemic dialysis was ac-
tually found to be associated with a fall in plasma
catecholamine concentrations. Hypokalemia has
been found to be associated with dysautonomia in
patients with primary hyperaldosteronism [17]. It is
possible that in patients with advanced renal failure,
who already have a propensity for autonomic in-
sufficiency [15], a fall in plasma potassium may un-
cover or cause impairment in sympathetic responses.
In support of this suggestion is the observation in the
present study that a significant increase in pulse rate
occurred during ultrafiltration in isokalemic but not
hypokalemic hemodialysis. More definitive studies,
however, are required to investigate this possibility.
In conclusion, the present results demonstrate that
hypokalemia may dominate over volume depletion
and a rise in plasma renin activity to suppress plasma
aldosterone concentrations in patients with advanced
renal failure, These patients also were shown to have
high plasma catecholamine concentrations which are
not stimulated by either isokalemic or hypokalemic
ultrafiltration dialysis and a mean fall in blood pres-
sure of 18 mm Hg. These high catecholamine concen-
trations may have pathogenetic importance both in
the hypertension and dialysis hypotension syndromes
observed in this population of patients. Lastly, the
lack of increase in heart rate and a fall in cate-
cholamines during hypokalemic ultrafiltration
dialysis suggest that hypokalemia may either cause or
uncover autonomic insufficiency in this group of pa-
tients already prone to this disorder.
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